Report - Subcutaneous Ustekinumab Provides Clinical Benefit for Two ... · ustekinumab in patients with anti-tumor necrosis factor (anti-TNF) refractory CD. Methods: We performed a retrospective

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form